Used primarily in pharmaceutical research as an intermediate in the synthesis of biologically active compounds. The iodine substituent enables potential applications in radiolabeling for medical imaging, such as positron emission tomography (PET), where it can be replaced with radioisotopes. It shows promise in the development of kinase inhibitors, crucial for cancer therapy by regulating cell signaling pathways. Additionally, it is investigated for creating selective ligands for neurological receptors, relevant to central nervous system drug discovery. Its indazole core with methoxy and iodo substituents supports medicinal chemistry efforts to optimize potency and selectivity in small molecule drugs.